FDPS and cancer: In vitro and in vivo antitumor effect of IPA have been commonly, but not exclusively, associated with FDPS inhibition, a key enzyme involved in mevalonate pathway—responsible for cholesterol biosynthesis and protein prenylation—widely involved in cancer [1,5,34].